McDermott Will & Emery represented Inhibikase Therapeutics, Inc. in the transaction. Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the...
McDermott Will & Emery represented Inhibikase Therapeutics, Inc. in the transaction. Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the...